Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Recombinant human alpha-1-antitrypsin (respiratory use)

EU orphan designation number: EU/3/01/041
Active ingredient: Recombinant human alpha-1-antitrypsin (respiratory use)
Indication: Treatment of emphysema secondary to congenital alpha 1-antitrypsin deficiency
Sponsor: Talecris Biotherapeutics GmbH
Lyoner Strasse 15, D-60528 Frankfurt am Main, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/05/2001 Centralised Orphan - Designation EMEA/OD/066/00 (2001)1504 of 30/05/2001
27/03/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/066/00/T/01 (2007)1448 of 23/03/2007
19/12/2008 Centralised Orphan - Removal of orphan designation from Community Register